EMPAgliflozin in Heart Failure With PReserved Ejection Fraction and End Stage Renal Disease

Clinical trial NCT06249945 · RECRUITING

Trial details

NCT number: NCT06249945
Sponsor: National Taiwan University Hospital
Status: RECRUITING
Phase: Phase 4
Study type: INTERVENTIONAL

Heart Failure With Preserved Ejection Fraction End Stage Renal Disease on Dialysis

Start date: 2024-03-05
Primary completion: 2027-12-31
Enrollment: 150

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.